Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 181,500 | 108,000 | 60,500 | 128,900 | 90,800 |
| Depreciation Amortization | 44,500 | 29,100 | 14,200 | 55,600 | 41,300 |
| Income taxes - deferred | -4,300 | 600 | 1,700 | -27,800 | -2,100 |
| Accounts receivable | -52,100 | -62,100 | -51,900 | -68,500 | -68,800 |
| Other Working Capital | -60,500 | -88,400 | -94,800 | -34,800 | -87,600 |
| Other Operating Activity | -9,700 | 40,700 | 34,300 | 99,800 | 99,100 |
| Operating Cash Flow | $99,400 | $27,900 | $-36,000 | $153,200 | $72,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,100 | -300 | -200 | 35,400 | -600 |
| PPE Investments | 52,100 | 2,300 | 15,900 | 46,400 | 41,100 |
| Purchase Of Investment | -4,000 | -3,500 | -1,600 | -1,100 | 4,600 |
| Sale Of Investment | 9,000 | 4,200 | 3,200 | 5,500 | 30,900 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -27,400 | -400 |
| Other Investing Activity | 0 | 0 | 0 | -27,400 | -400 |
| Investing Cash Flow | $56,000 | $2,700 | $17,300 | $58,800 | $75,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 196,300 |
| Debt Issued | 129,300 | 99,300 | 30,000 | 206,300 | N/A |
| Debt Repayment | -202,200 | -157,700 | -77,700 | -112,100 | -62,100 |
| Common Stock Issued | 43,900 | 33,200 | 16,700 | 63,800 | 50,700 |
| Common Stock Repurchased | -79,600 | -54,500 | -26,800 | -306,500 | -285,500 |
| Other Financing Activity | 12,900 | 10,300 | 3,900 | 14,400 | 12,100 |
| Financing Cash Flow | $-95,700 | $-69,400 | $-53,900 | $-134,100 | $-88,500 |
| Exchange Rate Effect | 9,200 | 3,200 | 600 | -1,000 | 800 |
| Beginning Cash Position | 218,700 | 218,700 | 218,700 | 141,800 | 141,800 |
| End Cash Position | 287,600 | 183,100 | 146,700 | 218,700 | 202,400 |
| Net Cash Flow | $68,900 | $-35,600 | $-72,000 | $76,900 | $60,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 99,400 | 27,900 | -36,000 | 153,200 | 72,700 |
| Capital Expenditure | -40,300 | -28,200 | -11,100 | -50,600 | -32,900 |
| Free Cash Flow | 59,100 | -300 | -47,100 | 102,600 | 39,800 |